1-hexadecyl-2-acetyl-glycero-3-phosphocholine and adenosine

1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with adenosine in 53 studies

Compound Research Comparison

Studies (1-hexadecyl-2-acetyl-glycero-3-phosphocholine)	Trials (1-hexadecyl-2-acetyl-glycero-3-phosphocholine)	Recent Studies (post-2010) (1-hexadecyl-2-acetyl-glycero-3-phosphocholine)	Studies (adenosine)	Trials (adenosine)	Recent Studies (post-2010) (adenosine)
9,156	187	552	32,536	1,075	8,930

Protein Interaction Comparison

Protein	Taxonomy	adenosine (IC50)
high affinity choline transporter 1 isoform a	Homo sapiens (human)	0.3851
Sodium/nucleoside cotransporter 1	Homo sapiens (human)	5.5
Sodium/nucleoside cotransporter 2	Homo sapiens (human)	5.5
Adenosine receptor A3	Homo sapiens (human)	0.0011
Adenosine receptor A1	Homo sapiens (human)	0.0023
Equilibrative nucleoside transporter 1	Homo sapiens (human)	63
Solute carrier family 28 member 3	Homo sapiens (human)	3.3

Research

Studies (53)

Timeframe	Studies, this research(%)	All Research%
pre-1990	12 (22.64)	18.7374
1990's	34 (64.15)	18.2507
2000's	6 (11.32)	29.6817
2010's	1 (1.89)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ito, S; Mikawa, H; Tsuruta, S	2
Bohlin, L; Rolfsen, W; Tuominen, M	1
Karaulov, AV; Melkova, OM; Porodenko, NV; Prokudin, VIu	1
Ekholm, J; Hanahan, DJ; Nouchi, T; Tatsumi, Y	1
Analouei, AR; Corcoran, PC; Foegh, ML; Katz, NM; Rajan, SS; Wallace, RB; Wang, Y	1
Kobayashi, K; Takabatake, T; Ushiogi, Y	1
Alloatti, G; Camussi, G; Montrucchio, G	1
Chambaut-Guerin, AM; Delbourg, I; Ribier, A; Thomopoulos, P; Ventura, MA	1
Haslam, RJ; Maurice, DH	1
Fenton, JW; Gudewicz, PW; Kaplan, JE; Moon, DG; van der Zee, H; Weston, LK	1
Howell, RE	1
Liu, T; Makowka, L; Nalesnik, M; Walsh, TR	1
Charlier, A; Keyeux, A; Pouleur, H; Raigoso, J; Schröder, E; Van Mechelen, H	1
Keery, RJ; Lumley, P	1
Barer, GR; Cai, YN; Emery, CJ; Russell, PC	1
Hayashi, H; Inoue, K; Kato, T; Kudo, I; Nojima, S; Nozawa, R	1
Hackenthal, E; Taugner, R	1
Bushfield, M; MacIntyre, DE; MacMillan, LJ; McNicol, A; Moffat, KJ; Murdoch, FA; Rossi, AG; Thomson, A	1
Barnes, PJ	2
Altman, R; Scazziota, A	1
Makowka, L; Ontell, SJ; Ove, P; Starzl, TE	1
Chand, N; Diamantis, W; Mahoney, TP; Sofia, RD	1
Wasserman, SI	1
Dangelmaier, C; Hassell, B; Holmsen, H; Rao, AK; Smith, JB; Willis, J	1
Martin, JG	1
Becker, BF; Raschke, P	1
Hashikura, Y; Ikegami, T; Kawasaki, S; Makuuchi, M; Matsunami, H; Nakazawa, Y	1
Bel-Haouari, M; Boudjema, K; Chenard, MP; Cinqualbre, J; Doghmi, M; Jaeck, D; Takada, Y; Wolf, P	1
Agarwal, KC; Clarke, E; Parks, RE; Rounds, S	1
Cordes, JF; O'Flaherty, JT	1
Green, PG; Heller, P; Levine, JD; Luo, J	1
Bull, DA; Hendrix, MJ; Hunter, GC; Larson, DF; Putnam, CW; Seftor, EA	1
Broadley, KJ; Thorne, JR	1
Asako, H; Granger, DN; Wolf, RE	1
Harris, T; Stewart, AG	1
Walker, BA	1
Becker, BF; Habazettl, H; Kupatt, C; Seligmann, C; Zahler, S	1
Bai, TR; Jacobson, MA; Knight, DA; Salvatore, CA; Walker, BA; Weir, T; Zhou, D	1
Bai, T; Jacobson, M; Knight, D; Rocchini, C; Walker, B; Zheng, X	1
Thijs, A; Thijs, LG	1
Akbaş, N; Barlas, A; Küçükhüseyin, C; Oncel, H; Payat, M; Silan, C	1
Chapman, ID; Chilvers, ER; Handley, DA; Morley, J; Templeton, AG	1
Borgeat, P; Krump, E	1
Held, HD; Martin, C; Uhlig, S	1
Baker, CJ; Barr, ML; Darbinian, SH; Kim, JD; Marcus, KA; Quardt, SM; Roberts, RF; Starnes, VA	1
Degawa, H; Hama, K; Iwamoto, H; Kikuchi, K; Kozaki, K; Kozaki, M; Matsuno, N; Nagao, T; Narumi, Y; Takeuchi, H; Uchiyama, M	1
Baumann, G; Felix, SB; Stangl, K; Stangl, V	1
Akbaş, N; Barlas, A; Küçükhüseyin, C; Seçkin, I; Silan, C; Yillar, DO	1
Anderson, R; Steel, HC	1
Borgeat, P; Bourgoin, SG; Flamand, N; Lapointe, G; Lefebvre, J; Lemieux, L; Picard, S	1
Dobson, GP; Granfeldt, A; Jiang, R; Shi, W; Vinten-Johansen, J	1

Reviews

9 review(s) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and adenosine

Article	Year
[Miscellaneous factors on mechanisms of blood pressure regulation]. Nihon rinsho. Japanese journal of clinical medicine, 1992, Volume: 50 Suppl Topics: Adenosine; Animals; Blood Pressure; Glucagon; Histamine; Humans; Hypertension; Lipids; Neuropeptide Y; Platelet Activating Factor; Thyroid Hormones	1992
Hormonal signals and intracellular messengers for renin secretion. Molecular and cellular endocrinology, 1986, Volume: 47, Issue:1-2 Topics: Acetylcholine; Adenosine; Adenylyl Cyclases; Adrenergic alpha-Agonists; Angiotensin II; Animals; Atrial Natriuretic Factor; Calcium; Cyclic AMP; Cyclic GMP; Dopamine; Epinephrine; Histamine; Hormones; Nerve Tissue Proteins; Neuropeptide Y; Norepinephrine; Platelet Activating Factor; Prostaglandins; Renin; Vasopressins	1986
Receptors and receptor mechanisms of endogenous platelet stimulatory and inhibitory mediators. Agents and actions. Supplements, 1986, Volume: 20 Topics: Adenosine; Adenosine Diphosphate; Blood Platelets; Epinephrine; Epoprostenol; Humans; Platelet Activating Factor; Platelet Aggregation; Prostaglandin D2; Prostaglandins D; Receptors, Cell Surface; Serotonin; Structure-Activity Relationship; Thrombin; Thromboxane A2; Vasopressins	1986
Inflammatory mechanisms and nocturnal asthma. The American journal of medicine, 1988, Jul-29, Volume: 85, Issue:1B Topics: Adenosine; Asthma; Blood Platelets; Circadian Rhythm; Eosinophils; Epithelium; Histamine; Humans; Inflammation; Lymphocytes; Macrophages; Mast Cells; Neutrophils; Platelet Activating Factor; Prostaglandins; SRS-A	1988
Mast cell mediators in the blood of patients with asthma. Chest, 1985, Volume: 87, Issue:1 Suppl Topics: Adenosine; Antigens; Asthma; Bronchial Spasm; Chemotactic Factors; Histamine; Humans; Mast Cells; Platelet Activating Factor; Urticaria	1985
[Animal models of bronchial hyperreactivity]. Revue des maladies respiratoires, 1994, Volume: 11, Issue:2 Topics: Adenosine; Animals; Asthma; Bradykinin; Bronchial Hyperreactivity; Bronchial Provocation Tests; Chronic Disease; Cytokines; Dextrans; Disease Models, Animal; Dogs; Guinea Pigs; Inflammation; Leukotrienes; Lipoxygenase; Mast Cells; Ozone; Platelet Activating Factor; Prostaglandin-Endoperoxide Synthases; Tachykinins	1994
Pathogenesis of renal failure in sepsis. Kidney international. Supplement, 1998, Volume: 66 Topics: Acute Kidney Injury; Adenosine; Endothelin-1; Humans; Interleukins; Leukotrienes; Nitric Oxide; Platelet Activating Factor; Renal Circulation; Sepsis; Tumor Necrosis Factor-alpha	1998
Adenosine. An endogenous inhibitor of arachidonic acid release and leukotriene biosynthesis in human neutrophils. Advances in experimental medicine and biology, 1999, Volume: 447 Topics: Adenosine; Animals; Arachidonic Acid; Humans; Leukotriene B4; Neutrophils; Phosphodiesterase Inhibitors; Phospholipases A; Phospholipases A2; Phosphorylation; Platelet Activating Factor; Theophylline	1999
Negative inotropic mediators released from the heart after myocardial ischaemia-reperfusion. Cardiovascular research, 2002, Volume: 53, Issue:1 Topics: Adenosine; Anti-Arrhythmia Agents; Arachidonic Acids; Coronary Vessels; Cytokines; Electrophysiology; Endothelium, Vascular; Free Radicals; Humans; Myocardial Contraction; Myocardial Reperfusion Injury; Myocardium; Nitric Oxide; Platelet Activating Factor; Reactive Oxygen Species	2002

Other Studies

44 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and adenosine

Article	Year
Adenosine inhibits divalent cation influx across human neutrophil plasma membrane via surface adenosine A2 receptors. Cellular signalling, 1992, Volume: 4, Issue:5 Topics: Adenosine; Adenosine Deaminase; Adult; Calcium; Cations, Divalent; Cell Membrane; Humans; In Vitro Techniques; Ion Transport; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Platelet Activating Factor; Receptors, Purinergic; Theophylline	1992
Effects of Calaguala and an active principle, adenosine, on platelet activating factor. Planta medica, 1992, Volume: 58, Issue:4 Topics: Acetylation; Adenosine; Cells, Cultured; Exocytosis; Humans; Neutrophils; Pancreatic Elastase; Plant Extracts; Plants, Medicinal; Platelet Activating Factor	1992
[Modulating effects of adenosine on the process of human platelet activation]. Biulleten' eksperimental'noi biologii i meditsiny, 1992, Volume: 113, Issue:6 Topics: Adenosine; Adenosine Diphosphate; Humans; Platelet Activating Factor; Platelet Activation; Platelet Aggregation; Platelet Aggregation Inhibitors; Serotonin	1992
The human platelet as a reproducible and sensitive cell for the detection and assay of platelet-activating factor. Analytical biochemistry, 1992, Volume: 204, Issue:1 Topics: Adenosine; Adenosine Diphosphate; Adult; Biological Assay; Blood Platelets; Citric Acid; Female; Fibrinogen; Glucose; Humans; In Vitro Techniques; Male; Platelet Activating Factor; Platelet Aggregation; Reproducibility of Results; Serotonin	1992
Platelet activating factor antagonist enhances lung preservation in a canine model of single lung allotransplantation. The Journal of thoracic and cardiovascular surgery, 1992, Volume: 104, Issue:1 Topics: Adenosine; Allopurinol; Animals; Deferoxamine; Diterpenes; Dogs; Ginkgolides; Glutathione; Insulin; Lactones; Lung; Lung Transplantation; Male; Organ Preservation; Organ Preservation Solutions; Platelet Activating Factor; Raffinose; Reperfusion Injury; Solutions; Tissue Preservation	1992
Prostacyclin inhibits the platelet-dependent effects of platelet-activating factor in the rabbit isolated heart. Journal of cardiovascular pharmacology, 1990, Volume: 15, Issue:5 Topics: Adenosine; Animals; Blood Platelets; Coronary Circulation; Dose-Response Relationship, Drug; Electrophysiology; Epoprostenol; Heart; Hemodynamics; In Vitro Techniques; Myocardial Contraction; Platelet Activating Factor; Rabbits	1990
The adhesiveness of monocytic U937 cells is stimulated by pro-inflammatory agents and inhibited by adenosine 3':5'-cyclic monophosphate. Biochemical pharmacology, 1990, Feb-15, Volume: 39, Issue:4 Topics: 2-Chloroadenosine; 8-Bromo Cyclic Adenosine Monophosphate; Adenosine; Alprostadil; Bucladesine; Calcitriol; Cell Adhesion; Cell Differentiation; Cell Line; Cyclic AMP; Diglycerides; Humans; Kinetics; Leukotriene B4; Monocytes; N-Formylmethionine Leucyl-Phenylalanine; Platelet Activating Factor; Tretinoin	1990
Molecular basis of the synergistic inhibition of platelet function by nitrovasodilators and activators of adenylate cyclase: inhibition of cyclic AMP breakdown by cyclic GMP. Molecular pharmacology, 1990, Volume: 37, Issue:5 Topics: Adenosine; Adenylyl Cyclases; Alprostadil; Animals; Blood Platelets; Cyclic AMP; Cyclic GMP; Enzyme Activation; Ferricyanides; Hemoglobins; In Vitro Techniques; Kinetics; Molsidomine; Nitroprusside; Platelet Activating Factor; Platelet Aggregation; Platelet Aggregation Inhibitors; Quinolones; Rabbits; Radioimmunoassay; Vasodilator Agents	1990
Platelet modulation of neutrophil superoxide anion production. Thrombosis and haemostasis, 1990, Feb-19, Volume: 63, Issue:1 Topics: Adenosine; Animals; Blood Platelets; Humans; In Vitro Techniques; Neutrophils; Platelet Activating Factor; Platelet Aggregation Inhibitors; Sheep; Superoxides; Thrombin; Xanthine Oxidase	1990
Multiple mechanisms of xanthine actions on airway reactivity. The Journal of pharmacology and experimental therapeutics, 1990, Volume: 255, Issue:3 Topics: 2',3'-Cyclic-Nucleotide Phosphodiesterases; Adenosine; Administration, Inhalation; Aerosols; Animals; Blood Pressure; Bronchi; Bronchoconstriction; Bronchodilator Agents; Carbachol; Guinea Pigs; Heart Rate; Histamine; Lung; Male; Ovalbumin; Platelet Activating Factor; SRS-A; Theophylline; Xanthines	1990
Improved preservation of the rat liver for orthotopic liver transplantation: use of University of Wisconsin-lactobionate solution and retrograde reflushing. Surgery, 1990, Volume: 108, Issue:5 Topics: Adenosine; Allopurinol; Animals; Bile; Free Radical Scavengers; Glutathione; Hypertonic Solutions; Insulin; Liver; Liver Transplantation; Male; Organ Preservation; Organ Preservation Solutions; Organ Size; Perfusion; Platelet Activating Factor; Quinolinium Compounds; Raffinose; Rats; Rats, Inbred Lew; Solutions; Survival Rate; Time Factors; Tissue Survival	1990
Alterations in endocardial vascular resistance after reperfusion in a low flow, high demand model of ischemia: effects of dipyridamole and WEB-2086, a platelet-activating factor antagonist. Journal of the American College of Cardiology, 1990, Volume: 16, Issue:7 Topics: Adenosine; Animals; Azepines; Coronary Vessels; Dipyridamole; Dogs; Hemodynamics; Myocardial Reperfusion Injury; Platelet Activating Factor; Triazoles; Vascular Resistance	1990
AH6809, a prostaglandin DP-receptor blocking drug on human platelets. British journal of pharmacology, 1988, Volume: 94, Issue:3 Topics: 1-Methyl-3-isobutylxanthine; 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Adenosine; Adenosine Diphosphate; Adenosine-5'-(N-ethylcarboxamide); Dinoprost; Epoprostenol; Humans; Hydantoins; In Vitro Techniques; Male; Platelet Activating Factor; Platelet Aggregation; Prostaglandin D2; Prostaglandin Endoperoxides, Synthetic; Receptors, Immunologic; Receptors, Prostaglandin; Xanthenes; Xanthones	1988
Reactivity and site of vasomotion in pulmonary vessels of chronically hypoxic rats: relation to structural changes. The American review of respiratory disease, 1989, Volume: 140, Issue:5 Topics: Adenosine; Adenosine-5'-(N-ethylcarboxamide); Almitrine; Angiotensin I; Animals; Bradykinin; Chronic Disease; Hypoxia; Male; Platelet Activating Factor; Pulmonary Circulation; Pyrazines; Rats; Rats, Inbred Strains; Reference Values; Respiration; Vasoconstriction; Vasodilator Agents; Vasomotor System	1989
A novel bioaction of PAF: induction of microbicidal activity in guinea pig bone marrow cells. Lipids, 1988, Volume: 23, Issue:12 Topics: 2-Chloroadenosine; Adenosine; Animals; Bone Marrow; Bone Marrow Cells; Candida; Carrageenan; Cells, Cultured; Guinea Pigs; Platelet Activating Factor; Platelet Membrane Glycoproteins; Receptors, Cell Surface; Receptors, G-Protein-Coupled	1988
Synergistic actions of paf-acether and sodium arachidonate in human platelet aggregation. 2. Unexpected results after aspirin intake. Thrombosis research, 1986, Jul-01, Volume: 43, Issue:1 Topics: 4,5-Dihydro-1-(3-(trifluoromethyl)phenyl)-1H-pyrazol-3-amine; Adenosine; Administration, Oral; Adult; Apyrase; Arachidonic Acids; Aspirin; Catechols; Drug Synergism; Epoprostenol; Humans; Indomethacin; Masoprocol; Platelet Activating Factor; Platelet Aggregation; Pyrazoles; Thromboxane B2; Time Factors; Umbelliferones	1986
Improved hepatic function in the 24-hour preserved rat liver with UW-lactobionate solution and SRI 63-441. Gastroenterology, 1988, Volume: 95, Issue:6 Topics: Adenosine; Allopurinol; Animals; Glutathione; Hypertonic Solutions; Insulin; Liver; Male; Organ Preservation; Organ Preservation Solutions; Platelet Activating Factor; Quinolinium Compounds; Raffinose; Rats; Rats, Inbred Lew; Solutions; Time Factors	1988
The amplifier role of platelet activating factor (PAF), other chemical mediators and antigen in the induction of airway hyperreactivity to cold. European journal of pharmacology, 1986, Apr-16, Volume: 123, Issue:2 Topics: Acetylcholine; Adenosine; Animals; Antigens; Asthma, Exercise-Induced; Atropine; Bronchial Spasm; Calcium; Cold Temperature; In Vitro Techniques; Muscle Contraction; Platelet Activating Factor; Potassium Chloride; Rats; Serotonin; Trachea	1986
Mediators and asthma. British journal of hospital medicine, 1985, Volume: 34, Issue:6 Topics: Adenosine; Asthma; Bradykinin; Bronchial Spasm; Chemotactic Factors; Chemotaxis, Leukocyte; Histamine; Humans; Lipoxygenase; Nerve Tissue Proteins; Platelet Activating Factor; Prostaglandins; SRS-A	1985
Platelet-activating factor is a weak platelet agonist: evidence from normal human platelets and platelets with congenital secretion defects. American journal of hematology, 1984, Volume: 17, Issue:2 Topics: Adenosine; Adenosine Triphosphate; Arachidonic Acid; Arachidonic Acids; Blood Platelet Disorders; Humans; Platelet Activating Factor; Platelet Aggregation; Serotonin; Thrombin; Thromboxanes	1984
Adenosine and PAF dependent mechanisms lead to myocardial reperfusion injury by neutrophils after brief ischaemia. Cardiovascular research, 1995, Volume: 29, Issue:4 Topics: Adenosine; Animals; Azepines; Guinea Pigs; Heart; Male; Myocardial Ischemia; Myocardial Reperfusion Injury; Neutrophil Activation; Neutrophils; Perfusion; Platelet Activating Factor; Receptors, Purinergic P1; Theobromine; Triazoles; Xanthines	1995
Effect of platelet-activating factor on cold-preserved liver grafts. The British journal of surgery, 1994, Volume: 81, Issue:12 Topics: Adenosine; Adenosine Triphosphate; Allopurinol; Animals; Cryopreservation; Glutathione; Insulin; Liver; Liver Transplantation; Male; Organ Preservation Solutions; Oxygen Consumption; Platelet Activating Factor; Raffinose; Rats; Rats, Wistar	1994
Effects of platelet-activating factor antagonist on preservation/reperfusion injury of the graft in porcine orthotopic liver transplantation. Transplantation, 1995, Jan-15, Volume: 59, Issue:1 Topics: Adenosine; Allopurinol; Animals; Glutathione; Graft Rejection; Insulin; Leukocyte Count; Liver; Liver Transplantation; Microscopy, Electron; Mitochondria, Liver; Organ Preservation Solutions; Piperidines; Platelet Activating Factor; Pyridinium Compounds; Raffinose; Reperfusion Injury; Swine; Tissue Preservation; Transaminases	1995
Platelet-activating factor (PAF)-induced platelet aggregation. Modulation by plasma adenosine and methylxanthines. Biochemical pharmacology, 1994, Nov-16, Volume: 48, Issue:10 Topics: Adenosine; Calcium; Humans; In Vitro Techniques; Platelet Activating Factor; Platelet Aggregation; Xanthines	1994
Human neutrophil degranulation responses to nucleotides. Laboratory investigation; a journal of technical methods and pathology, 1994, Volume: 70, Issue:6 Topics: Adenine Nucleotides; Adenosine; Arachidonic Acids; Cytoplasmic Granules; Diglycerides; Drug Synergism; Humans; In Vitro Techniques; Ionomycin; Leukotriene B4; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Platelet Activating Factor; Ribonucleotides; Structure-Activity Relationship; Tumor Necrosis Factor-alpha	1994
Modulation of bradykinin-induced plasma extravasation in the rat knee joint by sympathetic co-transmitters. Neuroscience, 1993, Volume: 52, Issue:2 Topics: Adenosine; Adenosine Triphosphate; Animals; Antihypertensive Agents; Arginine; Arthritis; Bradykinin; Dinoprostone; Male; Neuropeptide Y; Neurotransmitter Agents; Norepinephrine; Oxidopamine; Phenethylamines; Platelet Activating Factor; Rats; Rats, Sprague-Dawley; Sympathectomy, Chemical; Sympathetic Nervous System	1993
Putative vascular endothelial cell chemotactic factors: comparison in a standardized migration assay. The Journal of surgical research, 1993, Volume: 55, Issue:5 Topics: Adenosine; Animals; Cattle; Cells, Cultured; Chemotactic Factors; Chemotaxis; Endothelium, Vascular; Epidermal Growth Factor; Fibrinogen; Granulocyte-Macrophage Colony-Stimulating Factor; Growth Substances; Magnesium Sulfate; Platelet Activating Factor; Platelet-Derived Growth Factor; Pulmonary Artery; Transforming Growth Factor alpha	1993
Adenosine-induced bronchoconstriction in conscious hyperresponsive and sensitized guinea pigs. American journal of respiratory and critical care medicine, 1994, Volume: 149, Issue:2 Pt 1 Topics: Adenosine; Animals; Asthma; Bronchial Hyperreactivity; Bronchoconstriction; Carbachol; Guinea Pigs; Immunization; Male; Ovalbumin; Ozone; Platelet Activating Factor	1994
Leukocyte adherence in rat mesenteric venules: effects of adenosine and methotrexate. Gastroenterology, 1993, Volume: 104, Issue:1 Topics: Adenosine; Animals; Cell Adhesion; Endothelium, Vascular; Leukocyte Adherence Inhibition Test; Leukocytes; Leukotriene B4; Male; Methotrexate; Platelet Activating Factor; Purinergic Antagonists; Rats; Rats, Sprague-Dawley; Splanchnic Circulation; Venules	1993
Adenosine inhibits platelet-activating factor, but not tumour necrosis factor-alpha-induced priming of human neutrophils. Immunology, 1993, Volume: 78, Issue:1 Topics: Adenosine; Calcium; Cells, Cultured; Humans; Neutrophils; Platelet Activating Factor; Recombinant Proteins; Superoxides; Tumor Necrosis Factor-alpha	1993
Effects of adenosine and its analogues on actin polymerization in human polymorphonuclear leucocytes. Clinical and experimental pharmacology & physiology, 1993, Volume: 20, Issue:2 Topics: Actins; Adenosine; Adenosine Deaminase; Biopolymers; Complement C5a; Humans; In Vitro Techniques; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Pentostatin; Platelet Activating Factor; Theophylline	1993
Effects of adenosine on guinea pig pulmonary eosinophils. Inflammation, 1996, Volume: 20, Issue:1 Topics: Adenosine; Animals; Calcium; Eosinophils; Guinea Pigs; Ionomycin; Ionophores; Lung; Platelet Activating Factor; Receptors, Purinergic P1; Respiratory Hypersensitivity; Superoxides; Tetradecanoylphorbol Acetate	1996
[Interaction of adenosine with leukocytes and thrombocytes]. Zeitschrift fur Kardiologie, 1996, Volume: 85 Suppl 6 Topics: Adenosine; Animals; Blood Platelets; Endothelium, Vascular; Guinea Pigs; Myocardial Reperfusion Injury; Neutrophils; Platelet Activating Factor; Platelet Adhesiveness; Receptors, Purinergic P1	1996
Adenosine A3 receptor expression and function in eosinophils. American journal of respiratory cell and molecular biology, 1997, Volume: 16, Issue:5 Topics: Adenosine; Animals; Bronchi; Cells, Cultured; Chemotaxis, Leukocyte; Eosinophils; Gene Expression Regulation; Humans; Hypersensitivity, Immediate; Iodobenzenes; Lung; Lung Diseases, Obstructive; Mesoderm; Molecular Sequence Data; Platelet Activating Factor; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Receptors, Purinergic P1; RNA, Messenger; Sheep; Xanthines	1997
Adenosine A3 receptor stimulation inhibits migration of human eosinophils. Journal of leukocyte biology, 1997, Volume: 62, Issue:4 Topics: Adenosine; CD18 Antigens; Chemokine CCL5; Chemotaxis, Leukocyte; Eosinophils; Humans; In Vitro Techniques; L-Selectin; Leukotriene B4; Macrophage-1 Antigen; Platelet Activating Factor; Receptor, Adenosine A3; Receptors, Purinergic P1	1997
On the mechanisms of adenosine induced pulmonary vasoconstriction in rats. Journal of basic and clinical physiology and pharmacology, 1997, Volume: 8, Issue:4 Topics: Adenosine; Adrenergic Antagonists; Animals; Cyclooxygenase Inhibitors; Cyproheptadine; Dihydroergotoxine; Endothelium, Vascular; Female; Flavonoids; Ginkgo biloba; In Vitro Techniques; Indomethacin; Male; Methylene Blue; Plant Extracts; Platelet Activating Factor; Pulmonary Artery; Purinergic P1 Receptor Antagonists; Purinergic P2 Receptor Antagonists; Quinidine; Rats; Rats, Sprague-Dawley; Theophylline; Vasoconstriction	1997
Effects of S-salbutamol on human isolated bronchus. Pulmonary pharmacology & therapeutics, 1998, Volume: 11, Issue:1 Topics: Adenosine; Albuterol; Bradykinin; Bronchi; Bronchoconstriction; Bronchodilator Agents; Capsaicin; Histamine; Humans; Hypersensitivity; In Vitro Techniques; Leukotriene C4; Methacholine Chloride; Platelet Activating Factor	1998
Characterization of airway and vascular responses in murine lungs. British journal of pharmacology, 1999, Volume: 126, Issue:5 Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Adenosine; Animals; Bombesin; Bronchoconstriction; Bronchoconstrictor Agents; Dose-Response Relationship, Drug; Endothelin-1; Female; Histidine; In Vitro Techniques; Leukotriene C4; Lung; Methacholine Chloride; Mice; Mice, Inbred BALB C; Perfusion; Platelet Activating Factor; Serotonin; Substance P; Vasoconstriction; Vasoconstrictor Agents	1999
Platelet activating factor acetylhydrolase decreases lung reperfusion injury. The Annals of thoracic surgery, 2000, Volume: 70, Issue:2 Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Adenosine; Allopurinol; Animals; Glutathione; Hypertonic Solutions; In Vitro Techniques; Insulin; Lung; Male; Organ Preservation Solutions; Oxidative Stress; Phospholipases A; Platelet Activating Factor; Raffinose; Rats; Rats, Inbred Lew; Reperfusion Injury	2000
Beneficial effect of machine perfusion preservation on liver transplantation from non-heart-beating donors. Transplantation proceedings, 2000, Volume: 32, Issue:7 Topics: Adenosine; Allopurinol; Animals; Aspartate Aminotransferases; Cold Temperature; Endothelin Receptor Antagonists; Glutathione; Graft Survival; Heart Arrest; Hyaluronic Acid; Insulin; L-Lactate Dehydrogenase; Liver; Liver Transplantation; Organ Preservation; Organ Preservation Solutions; Peptides, Cyclic; Perfusion; Piperidines; Platelet Activating Factor; Pyridinium Compounds; Raffinose; Swine; Transplantation, Homologous	2000
Renovascular actions of adenosine in the isolated perfused rat kidney: possible underlying mechanisms. Journal of basic and clinical physiology and pharmacology, 2001, Volume: 12, Issue:4 Topics: Adenosine; Animals; Blood Pressure; Female; Guanosine Monophosphate; In Vitro Techniques; Kidney; Male; Nitric Oxide; Platelet Activating Factor; Prostaglandins; Rats; Rats, Sprague-Dawley; Receptors, Purinergic; Renal Circulation; Sympathetic Nervous System; Vasodilator Agents	2001
Dissociation of the PAF-receptor from NADPH oxidase and adenylate cyclase in human neutrophils results in accelerated influx and delayed clearance of cytosolic calcium. British journal of pharmacology, 2002, Volume: 136, Issue:1 Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Adenosine; Adenylyl Cyclases; Bucladesine; Calcium; Cyclic AMP; Cyclic Nucleotide Phosphodiesterases, Type 4; Cytosol; Homeostasis; Humans; In Vitro Techniques; Leukocyte Elastase; Luminescent Measurements; Membrane Potentials; N-Formylmethionine Leucyl-Phenylalanine; NADPH Oxidases; Neutrophil Activation; Neutrophils; Phenethylamines; Phosphodiesterase Inhibitors; Platelet Activating Factor; Platelet Membrane Glycoproteins; Purinergic P1 Receptor Agonists; Radioimmunoassay; Receptor, Adenosine A2A; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Rolipram; Spectrometry, Fluorescence; Superoxides	2002
Inhibition of platelet-activating factor biosynthesis by adenosine and histamine in human neutrophils: involvement of cPLA2alpha and reversal by lyso-PAF. Journal of leukocyte biology, 2006, Volume: 79, Issue:5 Topics: Adenosine; Adenosine A2 Receptor Agonists; Antihypertensive Agents; Cells, Cultured; Enzyme Inhibitors; Group IV Phospholipases A2; Histamine; Humans; Leukotrienes; MAP Kinase Signaling System; Membrane Lipids; Neutrophils; Phenethylamines; Phospholipases A; Phospholipids; Phosphorylation; Platelet Activating Factor; Pyrrolidines; Receptor, Adenosine A2A; Receptors, Formyl Peptide; Receptors, Histamine H2	2006
The nondepolarizing, normokalemic cardioplegia formulation adenosine-lidocaine (adenocaine) exerts anti-neutrophil effects by synergistic actions of its components. The Journal of thoracic and cardiovascular surgery, 2012, Volume: 143, Issue:5 Topics: Adenosine; Anesthetics, Local; Animals; Cardioplegic Solutions; CD11 Antigens; CD18 Antigens; Cell Adhesion; Cells, Cultured; Coculture Techniques; Coronary Vessels; Cytochalasin B; Dose-Response Relationship, Drug; Drug Combinations; Drug Synergism; Flow Cytometry; Lidocaine; Luminescent Measurements; N-Formylmethionine Leucyl-Phenylalanine; Neutrophil Activation; Neutrophils; Platelet Activating Factor; Superoxides; Swine; Time Factors; Transendothelial and Transepithelial Migration	2012